Literature DB >> 8174549

Role of hydroxyl radicals in the activation of human platelets.

L Iuliano1, J Z Pedersen, D Praticò, G Rotilio, F Violi.   

Abstract

Platelets primed by exposure to subthreshold concentrations of arachidonic acid or collagen are known to be activated by nanomolar levels of hydrogen peroxide. We here demonstrate that this effect is mediated by hydroxyl radicals (OHzero) formed in an extracellular Fenton-like reaction. H2O2-induced platelet aggregation, serotonin release and thromboxane A2 productions were inhibited by OHzero scavengers and by the iron chelator desferrioxamine; hydroxyl radicals were detected directly by ESR measurements of the spin-trapped OHzero adduct. The role of OHzero was confirmed in experiments with exogenously added iron; free or EDTA-bound ferrous iron activated platelets in a process blocked by deoxyribose, mannitol or catalase, whereas ferric iron was without effect unless reductants were included. The activation by OHzero depended on concomitant release of arachidonic acid and was blocked by the phospholipase A2 inhibitors mepacrine and aristolochic acid, and by the Na+/K+ antiporter inhibitor ethylisopropylamiloride. In contrast, neomycin and staurosporin were without effects, indicating that phospholipase C and protein kinase C were not involved in the initial phase of activation. Neither radical formation nor arachidonic acid release was blocked by aspirin. In whole blood aggregation of platelets could be induced by H2O2 generated upon specific stimulation of neutrophils by N-formyl-methionyl-leucyl-phenylalanine; platelet activation and radical formation were blocked by the NADPH oxidase inhibitor diphenyliodonium as well as by catalase and mannitol. These results suggest that reactive oxygen species act as 'second messengers' during the initial phase of the platelet activation process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174549     DOI: 10.1111/j.1432-1033.1994.tb18782.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo.

Authors:  Richard C Jin; Christopher E Mahoney; Laura Coleman Anderson; Filomena Ottaviano; Kevin Croce; Jane A Leopold; Ying-Yi Zhang; Shiow-Shih Tang; Diane E Handy; Joseph Loscalzo
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

Review 2.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

Review 3.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.

Authors:  L Iuliano; A R Colavita; C Camastra; V Bello; C Quintarelli; M Alessandroni; F Piovella; F Violi
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

5.  Tetrahydrobiopterin impairs the action of endothelial nitric oxide via superoxide derived from platelets.

Authors:  M Tajima; H Sakagami
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.

Authors:  C Calzada; E Vericel; M Lagarde
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

7.  Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells.

Authors:  Ya-yin Chen; Su-yin Chiang; Hsiu-ching Wu; Shung-te Kao; Chien-yun Hsiang; Tin-yun Ho; Jaung-geng Lin
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

8.  Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.

Authors:  M C Chang; B J Uang; C Y Tsai; H L Wu; B R Lin; C S Lee; Y J Chen; C H Chang; Y L Tsai; C J Kao; J H Jeng
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

Review 9.  Novel approach to reactive oxygen species in nontransfusion-dependent thalassemia.

Authors:  Paul I Tyan; Amr H Radwan; Assaad Eid; Anthony G Haddad; David Wehbe; Ali T Taher
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

10.  Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.

Authors:  Mei-Chi Chang; Hsiao-Hua Chang; Tong-Mei Wang; Chiu-Po Chan; Bor-Ru Lin; Sin-Yuet Yeung; Chien-Yang Yeh; Ru-Hsiu Cheng; Jiiang-Huei Jeng
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.